0001209191-23-023683.txt : 20230406 0001209191-23-023683.hdr.sgml : 20230406 20230406203630 ACCESSION NUMBER: 0001209191-23-023683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230404 FILED AS OF DATE: 20230406 DATE AS OF CHANGE: 20230406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Angio Paul CENTRAL INDEX KEY: 0001843748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 23807574 MAIL ADDRESS: STREET 1: C/O NEXIMMUNE, INC. STREET 2: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20877 FORMER NAME: FORMER CONFORMED NAME: D''Angio Paul DATE OF NAME CHANGE: 20210201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-04 0 0001538210 NexImmune, Inc. NEXI 0001843748 D'Angio Paul C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 1 0 0 0 0 Stock Option (right to buy) 1.82 2023-04-04 4 D 0 61678 D 2032-06-12 Common Stock 61678 0 D Stock Option (right to buy) 1.64 2023-04-04 4 A 0 61678 A 2032-06-12 Common Stock 61678 61678 D Stock Option (right to buy) 17.00 2023-04-04 4 D 0 9556 D 2031-02-10 Common Stock 9556 0 D Stock Option (right to buy) 1.64 2023-04-04 4 A 0 9556 A 2031-02-10 Common Stock 9556 9556 D Stock Option (right to buy) 4.31 2023-04-04 4 D 0 23122 D 2029-03-18 Common Stock 23122 0 D Stock Option (right to buy) 1.64 2023-04-04 4 A 0 23122 A 2029-03-18 Common Stock 23122 23122 D Stock Option (right to buy) 2.42 2023-04-04 4 D 0 12634 D 2037-03-02 Common Stock 12634 0 D Stock Option (right to buy) 1.64 2023-04-04 4 A 0 12634 A 2037-03-02 Common Stock 12634 12634 D The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. D'Angio's continued service on such vesting date. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 3, 2017, of which all of the shares subject to such option have vested. /s/ John Rudy, attorney-in-fact 2023-04-06